NURS 5338 (3) | The University of Texas at Arlington |
UPDATED Questions with 100% Verified Answers
Q1: Postprandial Glucose
A: The blood sugar level measured after eating,
which can indicate how well the body manages
glucose after meals.
Q2: Hemoglobin A1C
A: A blood test that measures the average blood
sugar levels over the past two to three months,
used to diagnose and monitor diabetes.
Q3: Lantus Insulin
A: A long-acting insulin used to help control blood
sugar levels in people with diabetes.
Q4: Carbohydrate Counting
A: A method of tracking carbohydrate intake to
manage blood sugar levels, particularly
important for people with diabetes.
Q5: Somogyi Effect
A: A phenomenon where low blood sugar during
the night causes a rebound increase in blood
sugar levels in the morning.
Q6: Dawn Phenomenon
A: A natural increase in blood sugar levels in the
early morning due to hormonal changes, not
related to previous low blood sugar.
Q7: Rebound Hyperglycemia
A: A term often used to describe the increase in
blood sugar that follows a hypoglycemic
episode.
Q8: Continuous Glucose Monitoring
A: A method of tracking blood sugar levels
Q9: (CGM)
, A: continuously throughout the day and night,
providing real-time data.
Q10: Otitis Externa
A: An infection of the outer ear canal, often
associated with water exposure, particularly
common in summer.
Q11: Heatstroke
A: A severe condition resulting from prolonged
exposure to high temperatures, leading to a
failure of the body's temperature regulation.
Q12: ASCVD Risk Estimator
A: A tool used to estimate the 10-year risk of
atherosclerotic cardiovascular disease, aiding in
treatment decisions.
Q13: Statin Therapy
A: Medications used to lower cholesterol levels in
the blood, particularly effective in reducing
cardiovascular risk.
Q14: Moderate-Intensity Statins
A: Statins that lower LDL cholesterol by 30-49%,
recommended for patients with diabetes aged
40-75 years.
Q15: High-Intensity Statins
A: Statins that lower LDL cholesterol by 50% or
more, recommended for patients with diabetes
at higher cardiovascular risk.
Q16: Insulin Resistance
UPDATED Questions with 100% Verified Answers
Q1: Postprandial Glucose
A: The blood sugar level measured after eating,
which can indicate how well the body manages
glucose after meals.
Q2: Hemoglobin A1C
A: A blood test that measures the average blood
sugar levels over the past two to three months,
used to diagnose and monitor diabetes.
Q3: Lantus Insulin
A: A long-acting insulin used to help control blood
sugar levels in people with diabetes.
Q4: Carbohydrate Counting
A: A method of tracking carbohydrate intake to
manage blood sugar levels, particularly
important for people with diabetes.
Q5: Somogyi Effect
A: A phenomenon where low blood sugar during
the night causes a rebound increase in blood
sugar levels in the morning.
Q6: Dawn Phenomenon
A: A natural increase in blood sugar levels in the
early morning due to hormonal changes, not
related to previous low blood sugar.
Q7: Rebound Hyperglycemia
A: A term often used to describe the increase in
blood sugar that follows a hypoglycemic
episode.
Q8: Continuous Glucose Monitoring
A: A method of tracking blood sugar levels
Q9: (CGM)
, A: continuously throughout the day and night,
providing real-time data.
Q10: Otitis Externa
A: An infection of the outer ear canal, often
associated with water exposure, particularly
common in summer.
Q11: Heatstroke
A: A severe condition resulting from prolonged
exposure to high temperatures, leading to a
failure of the body's temperature regulation.
Q12: ASCVD Risk Estimator
A: A tool used to estimate the 10-year risk of
atherosclerotic cardiovascular disease, aiding in
treatment decisions.
Q13: Statin Therapy
A: Medications used to lower cholesterol levels in
the blood, particularly effective in reducing
cardiovascular risk.
Q14: Moderate-Intensity Statins
A: Statins that lower LDL cholesterol by 30-49%,
recommended for patients with diabetes aged
40-75 years.
Q15: High-Intensity Statins
A: Statins that lower LDL cholesterol by 50% or
more, recommended for patients with diabetes
at higher cardiovascular risk.
Q16: Insulin Resistance
